Shubhayan Bhattacharya
-
Stock Market Highlights: Nifty, Sensex Clock Best Month In Nearly Two Years, Shrugging Off Iran War Concerns
The NSE Nifty 50 and the BSE Sensex rose over 7.4% each in April marking their biggest monthly gain since December 2023, when they had climbed 7.9%.
-
HUL Shares Fall Most In Over Two Months After Q4 Results, Price Hike Plan
Priya Nair said the Middle East crises has driven up costs of crude-linked commodities. "We are taking calibrated price increase of 2-5%," she said.
-
Vedanta Demerger Effect: Share Price Drops To Rs 290 From Rs 773
The share price settled at Rs 289.5 on NSE and Rs 290.5 on the BSE after the special trading session.
-
Bajaj Auto Shares Jump After Board Mulls Second Buyback In Two Years
Shares of Bajaj Auto Ltd. surged during early trade on Thursday after the board said it will consider a proposal to buy back shares in a meeting on May 6.
-
Nikkei, Kospi Fall In Early Asian Trade As Oil Spikes Over US-Iran Tensions
The benchmark Nikkei 225 shed1.3%, while the broader Topix fell 1.7%. South Korea's Kospi swung between gains and losses.
-
US Exim Bank Drags Reliance Power To Bankruptcy Court For $165 Million Default
The bank has filed an application under Section 7 of Insolvency and Bankruptcy Code (IBC), 2016 against the company, Reliance Power said in a stock exchange filing.
-
Federal Bank Q4 Results: Profit Meets Estimates, Provisions Rise, Dividend Announced
Federal Bank's standalone profit jumped 22% to Rs 1,259 crore in the January-March quarter.
-
Stock Market Today: Nifty, Sensex End Higher; RIL, ITC, Bharti Airtel Add Most
Stock Market Today: Intraday, the Nifty 50 reclaimed 24,300, rising 1.4%, and the BSE Sensex added over 1,000 points or 1.4% to just below 78,000.
-
Vedanta Q4 Results: Profit Beats Estimates, Revenue Up 12%
Vedanta's Q4 performance was led by growth in the aluminium and zinc segments.
-
Emcure Pharma Shares Hit Record High After Large Trades
The stock hit Rs 1,769 on the NSE, rising 10%, compared to a 1.4% jump in the benchmark Nifty 50 and nearly 1% advance in the Nifty Pharma index.
